BioLineRX Ltd (BLRX) is a publicly traded Healthcare sector company. As of May 19, 2026, BLRX trades at $2.73 with a market cap of $12.97M and a P/E ratio of 0.00. BLRX moved +0.00% today. Year to date, BLRX is -0.18%; over the trailing twelve months it is -13.73%. Its 52-week range spans $2.15 to $26.80. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces BLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
1 analysts cover BLRX: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $12.00.
| Metric | Value |
|---|---|
| Price | $2.73 |
| Market Cap | $12.97M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.80 |
| 52-Week Low | $2.15 |
| Volume | 1.15M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover BLRX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.